Drug Profile
CPL 001
Alternative Names: CPL001Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator University College London
- Class Anti-infectives; Antibacterials; Small molecules
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Sepsis
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for research development in Sepsis in United Kingdom (Parenteral)
- 15 Nov 2017 Early research in Sepsis in United Kingdom (Parenteral) before November 2017
- 15 Nov 2017 Critical Pressure plans a clinical trial for Sepsis in United Kingdom in early 2019